Anticoagulant Market Research Report 2022 by Product Type, Application, Region And Global Forecast to 2030 | JC MARKET RESEARCH
November 16, 2022 04:57 ET | JC Market Research
USA, Nov. 16, 2022 (GLOBE NEWSWIRE) -- “Glоbаl Anticoagulant Маrkеt” іѕ thе tіtlе оf а rесеntlу рublіѕhеd rероrt bу JCMR market research. Тhе rеѕеаrсh study іnvоlvеd ехреrt оріnіоn and with the help...
Lyophilized Injectable Drugs Market to hit USD 740 Billion by 2030, says Global Market Insights Inc.
October 11, 2022 06:10 ET | Global Market Insights Inc.
Selbyville, Delaware, Oct. 11, 2022 (GLOBE NEWSWIRE) -- The lyophilized injectable drugs market value is projected to reach USD 740 billion by 2030, according to a new research report by Global...
Straits Research Pvt Ltd
Heparin Market Size is projected to reach USD 11.89 Billion by 2030, growing at a CAGR of 6.8%: Straits Research
September 01, 2022 12:20 ET | Straits Research
New York, United States, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Heparin is an anticoagulant and glycosaminoglycan naturally produced by all mammals' basophils and mast cells. It prevents blood clots...
The Worldwide Cardiovascular Drugs Industry is Expected to Reach $96+ Billion by 2026
January 26, 2022 06:43 ET | Research and Markets
Dublin, Jan. 26, 2022 (GLOBE NEWSWIRE) -- The "Global Cardiovascular Drugs Market (2021-2026) by Drug Type, Disease Indications, Distribution Channel, Geography, Competitive Analysis and the Impact...
Global Heparin Market (2021 to 2027) - Featuring Pfizer, Sanofi and LEO Pharma Among Others
January 26, 2022 06:38 ET | Research and Markets
Dublin, Jan. 26, 2022 (GLOBE NEWSWIRE) -- The "Global Heparin Market By Type, By Application, By Route of Administration, By End Use, By Regional Outlook, COVID-19 Impact Analysis Report and...
Aronora Announces Clinical Data to Be Presented at the 63rd American Society of Hematology Annual Meeting
December 06, 2021 08:00 ET | Aronora, Inc
PORTLAND, Ore., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Aronora Inc., a clinical-stage biotechnology company developing innovative therapies for hematologic diseases, today announced that clinical data...
logo long.jpg
Acute Ischemic Stroke (AIS) Market to Surpass US$ 11,185.3 Million by 2028, Says Coherent Market Insights (CMI)
November 10, 2021 09:00 ET | CMI
SEATTLE, Nov. 10, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global acute ischemic stroke (AIS) market is estimated to be valued at US$ 8,517.0 Million in 2021 and is...
Insights on the Anticoagulants Global Market to 2025 - Rising Prevalence of Cardiovascular Disease is Driving Growth
September 22, 2021 08:28 ET | Research and Markets
Dublin, Sept. 22, 2021 (GLOBE NEWSWIRE) -- The "Global Anticoagulants Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025 Edition)" report has been added to...
_DXT9561-M Bristow
ARCA biopharma Announces Enrollment of First International Patient in Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19
September 16, 2021 08:30 ET | ARCA biopharma, Inc.
First international patient enrolled in BrazilTrial approximately 75% enrolledrNAPc2 development focused on unmet need for treatments in hospitalized COVID-19 patientsTopline trial data anticipated in...
ARCA Logo - JPEG.jpg
ARCA biopharma Announces Submission of PCT Patent Application for the Treatment of Coronavirus Infection and Associated Coagulopathy with rNAPc2
August 09, 2021 08:00 ET | ARCA biopharma, Inc.
WESTMINSTER, Colo., Aug. 09, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted...